What is it about?
This paper discusses recent advances in applying cell-penetrating peptide technology when coupled to nanosystems in breast and prostate cancer. First, we cover the basics of breast and prostate cancer, nanosystems, and the possible mechanisms cell-penetrating peptides use for drug delivery into cancer cells.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
The present work reviews nanoparticles coupled with Cell-penetrating peptides as guidance tools for breast cancer and prostate cancer cells and tumors, increasing their specificity and leading to less cytotoxicity against healthy tissue.
Perspectives
Encourage the development of new nanoparticles to increase their specificity and lead to less cytotoxicity against healthy tissue.
Sc.D. Hugo Gallardo Blanco
Universidad Autonoma de Nuevo Leon
Read the Original
This page is a summary of: Recent applications of cell-penetrating peptide guidance of nanosystems in breast and prostate cancer (Review), Oncology Letters, February 2022, Spandidos Publications,
DOI: 10.3892/ol.2022.13223.
You can read the full text:
Resources
Contributors
The following have contributed to this page
